MeSH term
Frequency | Condition_Probility | Apoptosis | 5 | 0.0 |
*Cell Cycle Proteins | 14 | 1.0 |
DNA Damage | 4 | 0.0 |
DNA Repair | 5 | 0.0 |
*DNA-Binding Proteins | 6 | 0.0 |
Humans | 39 | 0.0 |
Models, Biological | 5 | 0.0 |
Mutation | 5 | 0.0 |
*Nuclear Proteins | 8 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Oxygen/metabolism | 3 | 1.0 |
Protein Binding | 8 | 0.0 |
Proteins/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
Animals | 16 | 0.0 |
BRCA1 Protein/metabolism | 2 | 5.0 |
Female | 7 | 0.0 |
Male | 7 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 20 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Fanconi Anemia/*genetics/*metabolism | 2 | 40.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Mice | 6 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
CHO Cells | 4 | 0.0 |
Hamsters | 5 | 0.0 |
Hela Cells | 7 | 0.0 |
Phosphorylation | 3 | 0.0 |
Serine/*metabolism | 2 | 2.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Line | 8 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Mitomycin/pharmacology | 11 | 11.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 5 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Fanconi Anemia/genetics | 2 | 16.0 |
Genetic Complementation Test | 9 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Fanconi Anemia/*genetics/physiopathology | 2 | 66.0 |
Signal Transduction/physiology | 2 | 0.0 |
Alleles | 3 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Fanconi Anemia/*genetics | 6 | 12.0 |
Homozygote | 3 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mutagenesis | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Cell Cycle | 2 | 0.0 |
Child | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Adult | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Genotype | 4 | 0.0 |
Middle Aged | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Chromatin/chemistry | 2 | 11.0 |
Ubiquitin/metabolism | 2 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Precipitin Tests | 6 | 0.0 |
Transfection | 4 | 0.0 |
Fanconi Anemia/*metabolism | 4 | 33.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
RNA-Binding Proteins/genetics/*metabolism | 2 | 3.0 |
Cisplatin/pharmacology | 2 | 1.0 |
Cross-Linking Reagents/pharmacology | 3 | 2.0 |
DNA Mutational Analysis | 5 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Protein Biosynthesis | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Exons/genetics | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Chromosome Fragility | 2 | 3.0 |
Cell Fusion | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Alkylating Agents/pharmacology | 2 | 5.0 |
*Mutation | 5 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
*Genes, BRCA2 | 2 | 0.0 |
Jews/*genetics | 2 | 1.0 |
Cells, Cultured | 2 | 0.0 |
Genes, BRCA1 | 2 | 1.0 |
